Anskaffelsesforum – Implementering avny helseteknologi i sykehus

Oslo 24.mai 2018

Nils-Otto Ørjasæter

Service innovations

Not-commercial innovations Commercial innovations

Product innovations

Innovation Department Inven2

Sterile pre-drawn syringes. Benefits: Risk reduction and better use of expensive medicine.

Anew product for training of ankle after fracture. Benefits: Less days at hospital.

Medical isolation and transportation system. “Saving one – Protecting everyone.

Welfare technology –Monitoring critical health related parameters. Benefits: Better health for lower costs

Innovation activities at OUS

2015 2016 2017 Totalt

Registered inventions to Inven2 67 74 81 222

Patent applications 44 19 12 75

License agreements 25 25 18 68

New company establishments 2 3 1 6

Revenue from inventions in MNOK 17 17 15 49

Inven2 based innovations

Innovation Department based innovations

2015 2016 2017

Registered innentions to OUS 41 41 39

Insight and project design 17 15 7

Feasibility study 10 11 18

Pilot testing 5 7 4

Implementation 2 4 6

How to succeed with innovations within organizations'?Five fundamental elements

Why measuring effects of innovations?

Is it worthwhile starting an innovation development process?

To check if you are on the right track.

To help the colleges to understand the purpose of the innovation, and thereby reduce resistance against change.

To create an innovative culture and a learning organization.

To improve the communication with people involved.

To help the management making decisions.

The innovation process

The measurement process

The measurement process must be an integrated part of the innovation process

When to measure?

Parameters to be measured:• For WHAT purpose• WHEN?• HOW to measure

Transportation of the health care workers - not the patients.

Outreach wound team

Cost/benefit for the stakeholders implementing Outreached Wound Team

Total OUS costs per patient treatment 1.327 kr

Savings for the patients per treatment 266 kr

Savings for the municipality (Nursing homes) per treatment

1.264 kr

Savings for the sociaty in total per treatment 4.126 kr

… it is incompatible incentives between the stakeholders!

Financial analysis

The assessment should be summarized showing main results, conclusions and recommendations

Veileder for gjennomføring av nyttevurdering av innovasjoner i helsesektoren.